Aurobindo Pharma’s wholly owned arm Helix Healthcare will acquire an additional 20% stake in Luoxin Aurovitas Pharma in China for $5.1 million, strengthening its inhalation manufacturing footprint.
Macquarie said that Illumya, Sun Pharma’s largest product, generates a meaningful portion of its revenue from Medicare Part B. This raises the likelihood that the drug could fall within the scope of the proposed GLOBE model.
Mark Mobius, Chairman of Mobius Emerging Opportunities Fund, shared his outlook for 2026, warning that the AI sector is in “bubble-like territory” while naming India as his top emerging market pick. He plans to raise his India allocation to 30%,…
The Indian bond market is showing mixed trends, with government security yields rising to multi-month highs while corporate bond trading continues to expand. G-Sec yields have moved up due to the absence of RBI open market operations, higher US Treasury…
Through out its trading history, shares of Tata Capital have traded in a narrow range of ₹18, with a recent low of ₹315, and a high of ₹333.
Edelweiss AMC CIO Trideep Bhattacharya highlighted consumer discretionary and financials as key sectors, advised caution on IPOs, and said a sustained earnings recovery could favour equities over gold.
The brokerage said it expects over 80% of Groww’s FY28 revenue estimates to be driven by broking, making the business highly sensitive to any slowdown in trading activity.
Despite the recent rebound, shares of IRCON International are down 18% so far in 2025, which will be their worst calendar year return since its listing. From its July 2024 peak of ₹351, the stock is down 50%.
Silver prices hit all-time high, driven by supply deficits, strong industrial demand, and investor inflows.
The order adds to Shakti Pumps’ growing pipeline under various state and central solar-irrigation schemes, in September, the company had secured an order worth ₹374 crore from the MSEDCL for the supply and installation of 34,720 off-grid solar water pumping…